These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23276615)

  • 1. [New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation].
    Bosch M; Llop R; Lalueza P; Villar Mdel M
    Med Clin (Barc); 2013 Mar; 140(5):229-31. PubMed ID: 23276615
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral anticoagulants for stroke prevention in atrial fibrillation. Foreword.
    Rahimtoola SH
    Curr Probl Cardiol; 2014 Sep; 39(9):317. PubMed ID: 25194765
    [No Abstract]   [Full Text] [Related]  

  • 3. New oral anticoagulants: their role in stroke prevention in high-risk patients with atrial fibrillation.
    Ferns SJ; Naccarelli GV
    Med Clin North Am; 2015 Jul; 99(4):759-80. PubMed ID: 26042881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?
    Tzikas A; Freixa X; Ibrahim R
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1587-9. PubMed ID: 24215187
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.
    Katsnelson M; Sacco RL; Moscucci M
    Stroke; 2012 Apr; 43(4):1179-85. PubMed ID: 22454426
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possible Choice of New Oral Anticoagulants With Non-Valvular Atrial Fibrillation: a Review of Meta-Analyzes].
    Tatarskiĭ BA; Kazennova NV
    Kardiologiia; 2015; 55(3):97-105. PubMed ID: 26320297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Cardiol Clin; 2009 Feb; 27(1):125-35, ix. PubMed ID: 19111769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.
    Verheugt FW; Granger CB
    Lancet; 2015 Jul; 386(9990):303-10. PubMed ID: 25777666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
    Reicke B; Masuhr F; Weih M
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
    Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant therapy in atrial fibrillation: vitamin K antagonists or novel oral anticoagulant drugs?
    Riva N; Borg Xuereb C; Ageno W
    J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):139-41. PubMed ID: 25539157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preferences for oral anticoagulant treatment in the medium and long term prevention of stroke in non valvular atrial fibrillation].
    González-Rojas N; Giménez E; Fernández MÁ; Heineger AI; Martínez JL; Villar J; Lizán L
    Rev Neurol; 2012 Jul; 55(1):11-9. PubMed ID: 22718404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the current atrial fibrillation guidelines for stroke prevention need to be changed with the availability of new data on the new oral anticoagulants?
    Foley J; Lip GY
    Int J Clin Pract; 2012 May; 66(5):422-4. PubMed ID: 22512602
    [No Abstract]   [Full Text] [Related]  

  • 20. Another oral thrombin inhibitor for stroke prevention in atrial fibrillation?
    Eikelboom JW; Weitz JI
    Thromb Haemost; 2010 Mar; 103(3):481-3. PubMed ID: 20076857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.